A detailed history of Lynch Asset Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Lynch Asset Management, Inc. holds 44,900 shares of PFE stock, worth $1.19 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
44,900
Previous 44,500 0.9%
Holding current value
$1.19 Million
Previous $1.25 Million 4.34%
% of portfolio
0.55%
Previous 0.53%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$27.7 - $31.39 $11,080 - $12,556
400 Added 0.9%
44,900 $1.3 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $160,518 - $184,326
6,200 Added 16.19%
44,500 $1.23 Million
Q4 2023

Jan 26, 2024

BUY
$26.13 - $33.94 $478,179 - $621,102
18,300 Added 91.5%
38,300 $1.1 Million
Q1 2023

Apr 20, 2023

BUY
$39.39 - $51.28 $196,950 - $256,400
5,000 Added 33.33%
20,000 $816,000
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $619,800 - $918,750
15,000 New
15,000 $885,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lynch Asset Management, Inc. Portfolio

Follow Lynch Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lynch Asset Management, Inc. with notifications on news.